Human Phenotype Ontology

Hello! Guest! Please Login or Register! Clinician Mode

Examples Gene: MT-ND1, POLG, Region: M:1-1000 Variant: m.8993T>G, 1:g.10042757T>C rs3888511 MSCV_0000006, ClinVar: RCV000000015, Disease: Leigh syndrome, Phenotype: Retinopathy

Grandparent Node:
Abnormal peripheral nervous system synaptic transmission (HP:0030191)

Parent Node:
Response to drugs acting on neuromuscular transmission (HP:0030201)

..Starting node
..Unfavorable response of muscle weakness to acetylcholine esterase inhibitors (HP:0030203)

Term ID:

30203

Name:

Unfavorable response of muscle weakness to acetylcholine esterase inhibitors

Synonym:

Unfavourable response of muscle weakness to acetylcholine esterase inhibitors

Definition:

Lack of improvement of muscle strength in response to administration of an acetylcholine esterase inhibitor.

Comments:

Reference:

HP:0030203

Genes and Diseases:

Child Nodes:

Sister Nodes:

Favorable response of weakness to acetylcholine esterase inhibitors (HP:0030202)

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	HGNC ID	DiseaseId	DiseaseName	Frequency	ClinVar variants
HPO disease - gene - phenotype typical associations:
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0030203	HP:0030203	Unfavorable response of muscle weakness to acetylcholine esterase inhibitors	0	COLQ CL E G H	8292	2226	ORPHA:98915	Synaptic congenital myasthenic syndromes	HP:0040282 - Frequent	90
HP:0030203	HP:0030203	Unfavorable response of muscle weakness to acetylcholine esterase inhibitors	0	LAMB2 CL E G H	3913	6487	ORPHA:98915	Synaptic congenital myasthenic syndromes	HP:0040282 - Frequent	92

Genes (2) :COLQ LAMB2

Diseases (1) :ORPHA:98915

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.